US 8038997
Anti-marinobufagenin antibodies and methods for their use
granted A61KA61K2039/505A61P
Quick answer
US patent 8038997 (Anti-marinobufagenin antibodies and methods for their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61K, A61K2039/505, A61P, A61P9/00, A61P9/10